bpc 157 human clinical trials evidence review 2024 2025 ๐๐ปโโ๏ธ Is the lack of data in BPC-157 a red flag? โข If a drug could actually knit torn tendons back together in weeks, a trillion-dollar pharmaceutical industry probably wouldn't bury Regeneration or Risk? A Narrative
Description
People are regularly getting injections for a variety of reasons
[DOI] [PMC free article] [PubMed] [Google Scholar] Tarnawski AS, Ahluwalia A
This is understandable, as the field continues to prioritize data from double-blind, placebo-controlled, randomized, controlled trials (RCTs) as the benchmark for therapeutic adoption
Here is what we screen for
